Dianthus Therapeutics is a biotech company that develops therapeutics and drugs for people living with rare autoimmune diseases. They are committed to harnessing the power of selectivity in complement therapeutics to create transformative medicines.
Location: United States, Massachusetts, Waltham
Total raised: $100M
Investors 3
| Date | Name | Website |
| 21.06.2022 | 5AM Ventur... | 5amventure... |
| - | Catalio Ca... | cataliocap... |
| 28.05.2024 | Bain Capit... | baincapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.05.2022 | Series A | $100M | - |
Mentions in press and media 1
| Date | Title | Description |
| 04.05.2022 | Super rich individuals are private equity’s growing LP base | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. It’s been happening over a decade. Rather than settle on endowments or pension funds, the biggest... |